Denosumab and Pembrolizumab in Renal Cell Carcinoma: A Phase II Trial

Pook, David (Primary Chief Investigator (PCI))

Project: Research

Project Description

NMA HREC Reference Number: HREC/17/RPAH/159
NMA SSA Reference Number: SSA/18/MonH/14
Monash Health Ref: RES-18-0000-017X

Status	Finished
Effective start/end date	25/03/19 → 24/03/24

Keywords

clinical trial
phase 2 trial
treatment efficacy
renal cancer

Clinical Trial Phase

Phase II